Policy & Regulation
Artiva Biotherapeutics Raises USD 120m in series B Financing to Advance Pipeline of Allogeneic NK Cell Therapies
26 February 2021 - - US-based oncology-focused biopharmaceutical company Artiva Biotherapeutics, Inc has closed a USD 120m series B financing. New investor Venrock Healthcare Capital Partners led the ...
Japan's Kyowa Kirin partners with Harvard University to advance innovation in therapeutics and biomedical technology platforms
26 February 2021 - Japanese pharmaceutical company Kyowa Kirin Co Ltd (TSE:4151) announced on Thursday the launch of a five year strategic research alliance with Harvard University to help accelerate ...
GC Pharma submits BLA to US FDA for GC5107
26 February 2021 - South Korean biopharmaceutical company GC Pharma (KRX:006280) revealed on Thursday that it has submitted its Biologics License Application (BLA) for GC5107 (Immune Globulin Intraven...
AMRI to support Pfizer and BioNTech's COVID-19 Vaccine development in the fight against the pandemic
26 February 2021 - Contract research company Albany Molecular Research Inc (AMRI) said on Thursday that it has been selected to support the development and manufacture of lipid excipients for the Pfiz...
US FDA's vaccine advisers to consider third possible COVID-19 vaccine for US on 26 February 2021
26 February 2021 - CNN reported on Friday that the vaccine advisers of the US Food and Drug Administration (FDA) are scheduled to meet on 26 February 2021 to discuss the potential emergency authorisat...
The Muscular Dystrophy Association celebrates US FDA decision to grant casimersen accelerated marketing approval
26 February 2021 - The Muscular Dystrophy Association (MDA), an organisation committed to transforming the lives of people living with muscular dystrophy, ALS, and related neuromuscular diseases, is c...